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Although life-threatening ventricular dysrhythmias are uncommon in young
patients, there are underlying heart diseases that may predispose these pa-
tients to ventricular tachycardia or ventriCUlar fibrillation (VT\VF). To test the
hypothesis that tiered therapy with a pacemaker-cardioverter defibrillator
(PCD) is a therapeutic option for young patients at risk for sudden death,
we reviewed our experience with these devices. Nine patients. aged 9-33
years (17.7 ± 7, mean ± SO) at the time of implantation, received PCD's
between March, 1993, and the present. Post-operative diagnoses included
complete repair of tetralogy of Fallot (2), Senning for D-transposition of the
great arteries (1), double outlet right ventricle, status post ventricular septal
defect closure baffling the left ventricle to the aorta (1), and Fontan for sin-
gle ventricle with pulmonary stenosis (1). Other diagnoses included Wolff-
Parkinson-White (WPW) (1), WPW and dilated cardiomyopathy (1). arrhyth-
mogenic right ventricular dysplasia (1). and long OT syndrome (1). All pa-
tients had inducible or clinical unstable VT\VF before implantation except
one patient with WPW who had a family history of sudden death. Seven of
the patients had failed antiarrhythmics before implantation. Defibrillator elec-
trode configurations consisted of epicardial patches (4), transvenous alone
(3). and transvenous with subcutaneous patch(es) (2). In 10.4 ± 5 (range 2-
17) months of follow-up, overdrive pacing was successful in one patient, and
there have been appropriate defibrillator discharges in five patients (56%).
Seven of the nine patients remain on antiarrhythmics. There was only one
complication, a moderate pericardial effusion two months following transve-
nous lead implantation in a 24.9 kg nine-year old. No system has required
revision to date.
Conclusion: In relatively short-term follow-up over 50% of our patients
successfully have used tiered therapy from pacemaker-cardioverter defib-
rillators. This implies that these therapies protect selected young patients
from sudden cardiac death, potentially greatly increasing their life span.
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cured by a median of 7 RFC applications. Procedure duration was 3.4 ± 1.9
hours. with a median radiation exposure time of 29.0 minutes. During a 19
month follow-up (median), 20/22 infants were asymptomatic and required no
antiarrhythmic medication. Two pts had recurrences of SVT (1 PJRT). one of
which underwent a successful repeat session. Tachycardia related reduced
left ventricular function evolved to normal values in all 3 infants within the
follow-up period. There were no serious complications.
Conclusions: 1) RFC-ablation of accessory pathway-mediated supraven-
tricular tachycardia is feasible, safe and effective in children aged less than
6 years. 2) Reduced invasiveness due to simplified catheter techniques is
achievable in this particular patient population. 3) In children with an age <6
years, indication for RFC-ablation is restrictive and should be provided in pts
with severe symptoms due to drug-refractory SVT.
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To further examine the outcome of Fontan pts with pacemakers we evalu-
ated our database of 500 consecutive pts who underwent a Fontan operation
at Children's Hospital in Boston between April, 1973 and August 1991 (mean
follow up 3.5 ± 3.9 yrs, range 0-20.2 yrs). Pacemakers were implanted in 47
Long-term Outcome in Fontan Patients with
Pacemakers
Steven B. Fishberger, Gil Wernovsky. Thomas L. Gentles. Walter J. Gamble, John
E. Mayer Jr. Edward P. Walsh. Children's Hospital, Boston, MA
1904-51 I
Permanent Overdrive Atrial Pacing in Chronic
Management of Atrial Reentrant Tachycardias in
Postoperative Patients with Congenital Heart
Disease
Children Below 6 Years of Age with Accessory
Pathway Related Tachyarrhythmlas. Whom to
Ablate and How
Risk Factors for Venous Obstruction in Children
with Transvenous Pacing Leads
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To determine the incidence and risk factors for venous obstruction (OBST).
we prospectively evaluated with echocardiography 63 of 70 eligible children
who had transvenous pacing leads placed between 1985 and 1993. The me-
dian (range) age at initial implantation was 7.6 yrs (0.7, 16). and 8 patients
had subsequent additional implants. OBST was defined as a combination
of Doppler flow abnormalities in the SVC or innominate (InnV) vein and a
20 echo appearance of vessel narrowing andlor the clinical appearance of
dilated superficial veins. OBST was noted in 13/63 (21 %) patients, with loca-
tion of 08ST at the distal SUbclavian vein in 5, SVC in 4, InnV-SVC junction
in 2, and multiple sites in 2. Venography in 11 of these patients (2 refused)
showed that the severity of 08ST (as defined by % luminal narrowing) was
complete (100%) in 3 patients, severe (>90%) in 4, and moderate (60--90%)
in 4. Of the 8 patients who had additional implants, 3 (38%) had 08ST. Risk
factors for OBST in the remaining 55 single implant patients (10 with OBST;
18%) were explored. Patients with vs. without 08ST did not differ regarding
date or duration of implant, number of leads, lead material or the presence
of associated heart defects Or surgery. Patients with OBST were younger at
implant (median 5.6 vs. 8.8 yrs; p < 0.05). Total cross-sectional area of lead(sl
was related to body surface area at implant (RATIO). Patients with OBST had
higher mean RATIO (7.6 ± 1.6 mm 2 /m 2 ) than patients without 08ST (4.9
± 2.0 mm2 /m 2 ; p < 0.0002). After controlling for RATIO in multiple logistic
regression, no other variable predicted 08ST. Receiver-operator character-
istic curves showed a RATIO of >6.6 mm2/m 2 to best predict OBST, with a
sensitivity of 90% and specificity of 84%.
Conclusion: Since pacing is lifelong, sizing of transvenous leads to the
child is important to prevent 08ST and preserve venous access.
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By August 1994, a total of 103 children (:s15 yrs) underwent radio-frequency
current (RFC) ablation for accessory pathway (AP) mediated supraventricu-
lar tachycardia (SVT). Of these, 23 were infants aged less than 6 years (11
f, 12 m; 3.9 ± 1.6 yrs). All infants had suffered from recurrent or almost in-
cessant episodes of SVT, which were diagnosed at birth in 13 and prenatally
in 4. SVT was refractory to an antiarrhythmic regimen with 3 to 6 different
agents. Tachycardia-related symptoms included cardiac arrest in 2 infants
with WPW, syncope in 3 pts, reduced physical stress capacity in 11 and
SVT-related chest pain in 1. Thirteen pts had an overt AP. with an additional
concealed pathway in 2; the remaining 10 pts had a concealed Ap' in 6 of
which it sustained the permanent form of junctional reciprocating tachycar-
dia (PJRT). In the latter group 3 infants had reduced left ventricular function
(Fraction-shortening 13 to 21). In 11 infants, a single 5- or 6 French steerable
catheter was used for therapeutic intervention. In 9 infants a second catheter
was required for diagnostic purposes. Within 25 sessions. 22 infants were
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Sustained atrial tachycardias occurring after surgery for congenital heart dis-
ease. are often difficult to control by antiarrhythmic drugs and byantitachy-
cardia pacing. We implanted a permanent pacing system in 11 pts with drug
resistant recurrent atrial reentrant tachycardias. 7 pts were male and 4 fe-
male; mean age was 7.4 years (range 1 to 28 yrs); mean time from surgery
to the first documented atrial tachycardia was 2.2 years (range 1 month to 9
yrs). All pts had been unsuccessfully treated with two to five antiarrhythmic
drugs before pacing. At implantation the atrial pacing rate was programmed
to be 20% faster than the mean diurnal spontaneous rate. Individualized pro-
grams of pacemaker rate settings were then selected following serial 24
hours Holter monitoring, to obtain a prevailing paced atrial rhythm. Mean
follow-up was 3.4 years (range 6 mos to 5 yrs). 3 pts had recurrences of atrial
tachycardia during the first six months after the implantation, 8 pts remained
arrhythmia free. No patient had late recurrences and only two are still on an-
tiarrhythmic drug therapy. In conclusion: permanent overdrive atrial pacing
is a very useful tool in chronic management of postoperative atrial reentrant
tachycardias.
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